Active case detection of malaria in pregnancy using loop-mediated amplification (LAMP): a pilot outcomes study in South West Ethiopia.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
27 Aug 2020
Historique:
received: 22 06 2020
accepted: 18 08 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 7 4 2021
Statut: epublish

Résumé

125 million women are pregnant each year in malaria endemic areas and are, therefore, at risk of Malaria in Pregnancy (MiP). MiP is the direct consequence of Plasmodium infection during pregnancy. The sequestration of Plasmodium falciparum parasites in the placenta adversely affects fetal development and impacts newborn birth weight. Importantly, women presenting with MiP commonly develop anaemia. In Ethiopia, the Ministry of Health recommends screening symptomatic women only at antenatal care visits with no formal intermittent preventive therapy. Since MiP can display low-level parasitaemia, current tests which include microscopy and RDT are challenged to detect these cases. Loop mediated isothermal Amplification (LAMP) technology is a highly sensitive technique for DNA detection and is field compatible. This study aims to evaluate the impact of active malaria case detection during pregnancy using LAMP technology in terms of birth outcomes. A longitudinal study was conducted in two health centres of the Kafa zone, South West Ethiopia. Both symptomatic and asymptomatic pregnant women were enrolled in the first or second trimester and allocated to either Standard of Care (SOC-microscopy and RDT) or LAMP (LAMP, microscopy and RDT). Women completed at least three visits prior to delivery, and the patient was referred for treatment if Plasmodium infection was detected by any of the testing methods. The primary outcome was to measure absolute birth weight, proportion of low birth weight, and maternal/neonatal haemoglobin in each arm. Secondary outcomes were to assess the performance of microscopy and RDT versus LAMP conducted in the field. One hundred and ninety-nine women were included and assigned to either LAMP or SOC. Six were lost to follow up. In this cohort, 66.8% of women did not display any clinical symptoms and 70.9% were multi-parous. A reduced proportion of low birth weight newborns was observed in the LAMP group (0%) compared to standard of care (14%) (p <0.001). Improved neonatal haemoglobin was observed in the LAMP (13.1 g/dL) versus the SOC (12.8 g/dL) (p = 0.024) arm. RDT and microscopy had an analytical sensitivity of 66.7% and 55.6% compared to LAMP as a reference standard. These results support the use of highly sensitive tools for rapid on-site active case detection of MiP which may improve birth outcomes in the absence of IPT. However, further large-scale studies are required to confirm this finding.

Sections du résumé

BACKGROUND BACKGROUND
125 million women are pregnant each year in malaria endemic areas and are, therefore, at risk of Malaria in Pregnancy (MiP). MiP is the direct consequence of Plasmodium infection during pregnancy. The sequestration of Plasmodium falciparum parasites in the placenta adversely affects fetal development and impacts newborn birth weight. Importantly, women presenting with MiP commonly develop anaemia. In Ethiopia, the Ministry of Health recommends screening symptomatic women only at antenatal care visits with no formal intermittent preventive therapy. Since MiP can display low-level parasitaemia, current tests which include microscopy and RDT are challenged to detect these cases. Loop mediated isothermal Amplification (LAMP) technology is a highly sensitive technique for DNA detection and is field compatible. This study aims to evaluate the impact of active malaria case detection during pregnancy using LAMP technology in terms of birth outcomes.
METHODS METHODS
A longitudinal study was conducted in two health centres of the Kafa zone, South West Ethiopia. Both symptomatic and asymptomatic pregnant women were enrolled in the first or second trimester and allocated to either Standard of Care (SOC-microscopy and RDT) or LAMP (LAMP, microscopy and RDT). Women completed at least three visits prior to delivery, and the patient was referred for treatment if Plasmodium infection was detected by any of the testing methods. The primary outcome was to measure absolute birth weight, proportion of low birth weight, and maternal/neonatal haemoglobin in each arm. Secondary outcomes were to assess the performance of microscopy and RDT versus LAMP conducted in the field.
RESULTS RESULTS
One hundred and ninety-nine women were included and assigned to either LAMP or SOC. Six were lost to follow up. In this cohort, 66.8% of women did not display any clinical symptoms and 70.9% were multi-parous. A reduced proportion of low birth weight newborns was observed in the LAMP group (0%) compared to standard of care (14%) (p <0.001). Improved neonatal haemoglobin was observed in the LAMP (13.1 g/dL) versus the SOC (12.8 g/dL) (p = 0.024) arm. RDT and microscopy had an analytical sensitivity of 66.7% and 55.6% compared to LAMP as a reference standard.
CONCLUSIONS CONCLUSIONS
These results support the use of highly sensitive tools for rapid on-site active case detection of MiP which may improve birth outcomes in the absence of IPT. However, further large-scale studies are required to confirm this finding.

Identifiants

pubmed: 32854715
doi: 10.1186/s12936-020-03380-9
pii: 10.1186/s12936-020-03380-9
pmc: PMC7457308
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

305

Références

Clin Infect Dis. 2018 Nov 28;67(12):1890-1896
pubmed: 29733338
BMJ Open. 2018 Jan 8;8(1):e019014
pubmed: 29317419
J Infect Dis. 2019 Jul 2;220(3):457-466
pubmed: 30891605
Lancet Infect Dis. 2012 Dec;12(12):942-9
pubmed: 22995852
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32179528
Science. 1996 Jun 7;272(5267):1502-4
pubmed: 8633247
Clin Infect Dis. 2015 Feb 15;60(4):598-604
pubmed: 25362205
PLoS Med. 2010 Jan 26;7(1):e1000221
pubmed: 20126256
Malar J. 2018 Jul 13;17(1):262
pubmed: 30005616
J Clin Diagn Res. 2017 Jan;11(1):QC01-QC04
pubmed: 28274003
Adv Parasitol. 2012;80:151-201
pubmed: 23199488
Malar J. 2019 Nov 21;18(1):372
pubmed: 31752868
Malar J. 2011 Jun 24;10:173
pubmed: 21699741
Paediatr Perinat Epidemiol. 2018 Mar;32(2):184-196
pubmed: 29253317
Am J Trop Med Hyg. 2010 Jul;83(1):56-60
pubmed: 20595478
Malar J. 2009 Nov 22;8:262
pubmed: 19930609
Clin Microbiol Rev. 2004 Oct;17(4):760-9, table of contents
pubmed: 15489346
Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):
pubmed: 28213434
PLoS One. 2013 Sep 30;8(9):e75486
pubmed: 24098699
J Clin Microbiol. 2004 Sep;42(9):4237-41
pubmed: 15365017
Sci Rep. 2016 Nov 09;6:36808
pubmed: 27827432
J Infect Dis. 2012 Dec 15;206(12):1911-9
pubmed: 23045626
Am J Trop Med Hyg. 2007 May;76(5):849-54
pubmed: 17488903
Asian Pac J Trop Med. 2012 Oct;5(10):803-9
pubmed: 23043920
Malar J. 2012 Jun 18;11:204
pubmed: 22704733
Nature. 1998 Oct 29;395(6705):851-2
pubmed: 9804416
PLoS Negl Trop Dis. 2017 Jun 12;11(6):e0005606
pubmed: 28604825
Malar J. 2019 Sep 2;18(1):302
pubmed: 31477117
Trends Parasitol. 2020 Feb;36(2):127-137
pubmed: 31864896
Clin Infect Dis. 2015 May 15;60(10):1481-8
pubmed: 25694651
Malar J. 2014 May 07;13:174
pubmed: 24884606
Int J Parasitol. 2012 Nov;42(12):1099-105
pubmed: 23022617
Lancet. 2015 Dec 19;386(10012):2507-19
pubmed: 26429700
J Travel Med. 2014 May-Jun;21(3):195-200
pubmed: 24629014
Malar J. 2019 Oct 16;18(1):350
pubmed: 31619258
Malar J. 2013 Oct 01;12:349
pubmed: 24079306
Malar J. 2009 Jun 11;8:129
pubmed: 19519915
Malar J. 2013 Oct 03;12:352
pubmed: 24090230
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD000169
pubmed: 17054128
BMC Res Notes. 2019 May 27;12(1):290
pubmed: 31133048
Rev Med Virol. 2008 Nov-Dec;18(6):407-21
pubmed: 18716992
Med Mal Infect. 2020 Mar;50(2):141-160
pubmed: 31375372
BJOG. 2011 Jan;118(2):123-35
pubmed: 21159117
Malar J. 2013 Jun 10;12:195
pubmed: 23758883

Auteurs

Guluma Tadesse (G)

Institute of Health, School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.

Claire Kamaliddin (C)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada.

Cody Doolan (C)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada.

Ranmalee Amarasekara (R)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada.

Ruth Legese (R)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada.

Abu Naser Mohon (AN)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada.

James Cheaveau (J)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada.

Delenasaw Yewhalaw (D)

Institute of Health, School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
Tropical and Infectious Diseases Research Center, Jimma University, Jimma, Ethiopia.

Dylan R Pillai (DR)

Cumming School of Medicine, Department of Pathology & Laboratory Medicine, Diagnostic & Scientific Centre, The University of Calgary, Room 1W-416, 9-3535 Research Road NW, Calgary, AB, T2L 2K8, Canada. drpillai@ucalgary.ca.
Cumming School of Medicine, Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Calgary, Canada. drpillai@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH